Calendar IconSign Up for Keystone Heart Updates

(813) 530-8200

info@keystoneheart.com

Search

Europe FlagEUUsa FlagUS

Blog Category

Blog Category

Press Release Category

Press Release Category

News Category

News Category

29 Jul 2020

Posted at 08:45h in by
0 Likes

TAMPA, Fla., July 29, 2020 /PRNewswire/ -- Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced completion of the first worldwide commercial case using the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. Pieter Stella, MD, Assistant Professor, Medical Department of...

10 Mar 2020

Posted at 05:29h in by
0 Likes

TAMPA, Fla., March 10, 2020 /PRNewswire/ -- Keystone Heart Ltd., a Venus Medtech Company, today announced European CE Mark for the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. The device is designed to minimize the risk of cerebral damage by deflecting embolic debris away from cerebral circulation during...

Skip to content